The question of“new moral subjects”arises today in connection with the use of advanced technologies in the context of Industry 4.0,i.e.,the industrial enterprise investing in smart factories,co-robotic,additive manu...The question of“new moral subjects”arises today in connection with the use of advanced technologies in the context of Industry 4.0,i.e.,the industrial enterprise investing in smart factories,co-robotic,additive manufacturing,augmented reality,cyber security,big data,etc.Industry 4.0 underpins what is being heralded as Industry 5.0.Technologies in this field excel in that they are not used for the mere execution of processes designed,programmed,and controlled by man,but are applied to realise“autonomously”goals in the industrial context.Consequently,their degree of automation is no longer defined by increasing independence from human beings,but by the ability to spontaneously initiate a process and implement it to useful effect.The comparison between man and machine,and the justification for the introduction of“new moral subjects”thus crucially depend on the location of“moral being”in the reference to their“autonomy”as a property characterising the“subject man”,but not the exclusive prerogative of the latter.展开更多
In this study,we are discussing the rationale behind informed consent in clinical trials in developing countries.It elaborates how informed consent has remained an ethical and practical issue.Poverty,endemic diseases,...In this study,we are discussing the rationale behind informed consent in clinical trials in developing countries.It elaborates how informed consent has remained an ethical and practical issue.Poverty,endemic diseases,and a lack of investment in healthcare systems influence the ease of conducting and selecting trials that can benefit the people of developing countries.Differences in cultural perspectives,religious beliefs,a lack of formal training for clinical staff,children,time zone difference,literacy,vulnerable population,and language barriers for subject enrollment,protection,and informed are also challenges.This report doesn’t only highlight the right the wrongs of the past or reiterate cases where clinical trials have hurt subjects in developing countries.The current study investigates the conditions of human research in developing countries to make them more ethically sound.The extends proposals to investigators,scientists,governments,sponsors,and other groups who are interested where appropriate.展开更多
文摘The question of“new moral subjects”arises today in connection with the use of advanced technologies in the context of Industry 4.0,i.e.,the industrial enterprise investing in smart factories,co-robotic,additive manufacturing,augmented reality,cyber security,big data,etc.Industry 4.0 underpins what is being heralded as Industry 5.0.Technologies in this field excel in that they are not used for the mere execution of processes designed,programmed,and controlled by man,but are applied to realise“autonomously”goals in the industrial context.Consequently,their degree of automation is no longer defined by increasing independence from human beings,but by the ability to spontaneously initiate a process and implement it to useful effect.The comparison between man and machine,and the justification for the introduction of“new moral subjects”thus crucially depend on the location of“moral being”in the reference to their“autonomy”as a property characterising the“subject man”,but not the exclusive prerogative of the latter.
文摘In this study,we are discussing the rationale behind informed consent in clinical trials in developing countries.It elaborates how informed consent has remained an ethical and practical issue.Poverty,endemic diseases,and a lack of investment in healthcare systems influence the ease of conducting and selecting trials that can benefit the people of developing countries.Differences in cultural perspectives,religious beliefs,a lack of formal training for clinical staff,children,time zone difference,literacy,vulnerable population,and language barriers for subject enrollment,protection,and informed are also challenges.This report doesn’t only highlight the right the wrongs of the past or reiterate cases where clinical trials have hurt subjects in developing countries.The current study investigates the conditions of human research in developing countries to make them more ethically sound.The extends proposals to investigators,scientists,governments,sponsors,and other groups who are interested where appropriate.
